Apr 24, 2025 | Defective Drugs, Defective Medical Device, Defective Product, Depo-Provera, Product Liability
For decades, Depo-Provera has been marketed as a convenient and long-lasting form of birth control. The injectable contraceptive, also known as depot medroxyprogesterone acetate (DMPA), has been widely prescribed to millions of women in the United States and around...
Feb 19, 2025 | Defective Drugs, Defective Product, Depo-Provera, Product Liability
Depo-Provera is a widely used birth control injection that contains medroxyprogesterone acetate, a synthetic form of the hormone progesterone. It is administered every three months and is known for its high effectiveness in preventing pregnancy. However, over the...
Nov 19, 2024 | Defective Drugs, Defective Product, Depo-Provera, Product Liability
Depo-Provera, an injectable contraceptive containing the synthetic hormone medroxyprogesterone acetate (MPA), has been widely used for decades as an effective birth control method. While it is valued for its convenience and long-term efficacy, concerns have emerged...
Nov 5, 2024 | Defective Drugs, Defective Product, Depo-Provera, Personal Injury, Product Liability
Depo-Provera, a widely-used injectable contraceptive, has offered a convenient birth control option for millions of women worldwide. Yet, while the drug’s appeal has long rested on its effectiveness and quarterly dosing schedule, serious side effects and long-term...
Oct 24, 2024 | Defective Drugs, Depo-Provera, Product Liability
Depo-Provera, a popular birth control injection used by millions of women worldwide, has long been lauded for its convenience and efficacy. However, new evidence has surfaced that may change how women view this contraceptive option. Recent studies and emerging reports...
